Form 4: Outset Medical Director Andrea Lynn Saia Receives 25,000 Shares of Common Stock

Director Andrea Lynn Saia acquired 25,000 shares of Outset Medical common stock on May 29, 2024, as part of a grant that vests upon the earlier of one year or the next annual meeting.

Summary

• On May 29, 2024, Andrea Lynn Saia, a director of Outset Medical, Inc. acquired 25,000 shares of common stock.
• The acquisition was a grant, with the price per share being $0.00.
• These shares are in the form of Restricted Stock Units (RSUs) that will vest upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's next Annual Meeting of Stockholders.
• Following the transaction, Andrea Lynn Saia directly owns 47,892 shares of Outset Medical common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard equity grant to a director, which is generally viewed as a positive sign of alignment with shareholder interests.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders.

Industry Context

This type of transaction is common for directors and executives as part of their compensation packages, aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Equity grants to directors are a standard practice in publicly traded companies to incentivize performance and align interests with shareholders.
• The vesting schedule of one year or the next annual meeting is a typical vesting arrangement.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.

Key Dates